Understanding how Wolbachia bacteria can help control dengue and Zika virus spread
The Mechanism of Cytoplasmic Incompatibility
This study is looking at how a special bacteria called Wolbachia can help stop mosquitoes from spreading viruses like Zika and dengue, which could lead to fewer infections for people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State University, the NIH-funded |
| Lab location | 1 site (University Park, United States) |
| Project ID | NIH-10773207 on NIH RePORTER |
What this research studies
This research investigates the role of Wolbachia bacteria in blocking the replication of harmful viruses like Zika and dengue in mosquitoes. By understanding how these bacteria affect mosquito reproduction through a process called cytoplasmic incompatibility, the study aims to develop strategies to reduce mosquito populations or replace them with virus-resistant ones. The approach involves genetic analysis and field trials to assess the effectiveness of Wolbachia in controlling arboviral infections. Patients may benefit indirectly through reduced transmission of these viruses.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals living in regions affected by dengue and Zika virus transmission.
Not a fit: Patients who do not reside in areas where dengue or Zika viruses are prevalent may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative methods for controlling dengue and Zika virus outbreaks, ultimately protecting public health.
How similar studies have performed: Previous research has shown promise in using Wolbachia to control mosquito populations and reduce arboviral transmission, indicating a potential for success in this approach.
Where this research is happening
University Park, United States
- Pennsylvania State University, the — University Park, United States (Active)
Researchers
- Principal investigator: Bordenstein, Seth R — Pennsylvania State University, the
- Study coordinator: Bordenstein, Seth R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.